IVIg‐induced plasmablasts in patients with Guillain‐Barré syndrome

OBJECTIVE: The Guillain–Barré syndrome (GBS) is an acute, immune‐mediated disease of peripheral nerves. Plasmablasts and plasma cells play a central role in GBS by producing neurotoxic antibodies. The standard treatment for GBS is high‐dose intravenous immunoglobulins (IVIg), however the working mec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Clin Transl Neurol
Main Authors: Brem, Maarten D., Jacobs, Bart C., van Rijs, Wouter, Fokkink, Willem Jan R., Tio‐Gillen, Anne P., Walgaard, Christa, van Doorn, Pieter A., IJspeert, Hanna, van der Burg, Mirjam, Huizinga, Ruth
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6331722/
https://ncbi.nlm.nih.gov/pubmed/30656191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.687
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados